Making Clinical Trials Better for Everyone in 2023
Roundtable: What do you view as the most disruptive or transformational technology or development on the horizon?
Scrip Asks…What Does 2023 Hold For Biopharma? Part 5: Technological Advances
Technology diffusion strategies for CIOs and the VC mindset
Sanofi extends cooperation with Israel’s CytoReason for bowel disease drug discovery
Follow the Money: University of Chicago Funds Biotech Accelerator, Breakthrough Tankless Inhaled Nitric Oxide Delivery System, More
Sanofi, CytoReason expand AI deal into IBD
CytoReason expands deal with Sanofi to look at IBD
Sanofi and CytoReason Target IBD in Expanded Collaboration (Updated)
Sanofi taps CytoReason’s AI models to target bowel disease
